Searched for
SEKHMET PHARMAVENTURES
PAG elevates India head Nikhil Srivastava as Co-Head of Private EquityPAG has appointed Nikhil Srivastava as Co-Head of its Private Equity business, succeeding Lincoln Pan, who will become CEO of Jardine Mathe...- PAG acquires majority stake in packaging co PraveshaPAG, an Asia Pacific-focused private equity firm, acquires a majority stake in Pravesha Industries, a major pharmaceutical packaging compan...
- PAG to acquire Advent-owned Manjushree TechnopackAsia-focused private equity fund PAG is set to acquire Manjushree Technopack Ltd., India's largest rigid plastic packaging company, for $1 ...
- India takes tiny steps back from its China dependencyIndia is striving to reduce its dependency on China for pharmaceutical raw materials by promoting domestic production through a Production-...
- Pharma raw material makers in race to tank up on CXO talentSome of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...
- ADIA, HarbourVest eye minor stake in CohanceADIA and HarbourVest are in discussions to acquire a minority stake in Cohance Lifesciences, a pharmaceuticals platform owned by Advent Int...
- Nirma to acquire 75% of Glenmark’s API arm for Rs 5,615 crGlenmark Pharma’s stake in the leading active pharmaceutical ingredient (API) platform will drop to 7.84% from 82.84%. The transaction valu...
- ChrysCapital still in race to buy controlling stake in Glenmark Life SciencesPrivate equity firm ChrysCapital remains firmly in the running to buy Glenmark Pharma's stake in Glenmark Life Sciences (GLS) with rival bi...
- Nirma closes in on Glenmark's API arm, emerges sole contender as bid deadline endsNirma Group is likely to acquire an 82.84% stake in Glenmark Life Sciences in a deal worth INR 6,664 to INR 7,000 crore. The company has em...
- Washing powder maker Nirma and Sekhmet vie for $731 million Glenmark Life stake: SourcesNirma, known for its eponymous washing detergent brand, have entered the final round of bidding for a stake of about 83% in the Mumbai-list...
- Sekhmet, Nirma in fray for Glenmark's API businessSekhmet Pharmaventures and Nirma Group are in competition to acquire Glenmark Life Sciences (GLS), the 82.85% subsidiary of Glenmark Pharma...
- PAG-led Sekhmet Pharmaventures announces the hiring of Anil Khubchandani as MD and CEOKhubchandani, in his most recent role, has served as Co-CEO and Whole-time Director of Jubilant Ingrevia. Over his 20-year career at Jubila...
- PAG-led API Platform acquire controlling stake in OptimusFounded in 2004, Optimus is a vertically integrated manufacturer of pharmaceutical products, including advanced intermediates, active pharm...
- Stocks in the news: Harsha Engineers, BPCL, Coal India, Redington India and BritanniaHarsha Engineers is scheduled to make its Dalal Street debut on Monday as the company raised Rs 755 crore via its initial stake sale by sel...
- CCI clears deal involving Sekhmet Pharmaventures, Optimus DrugsIn a tweet on Friday, the watchdog said it has approved acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures as ...
- PAG, partners buy controlling stake in Optimus for Rs 2,000 crorePAG, a leading alternative investment firm focused on Asia-Pacific, along with consortium partners CX Partners and Samara Capital, on Wedne...
Load More
